SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Beyond Meat, Inc. engages in the provision of plant-based meats. Its products include ready-to-cook meat under The Beyond Burger and Beyond Sausage brands, and frozen meat, namely, Beyond Chicken Strips and Beyond Beef Crumbles. The company was founded by Ethan Walden Brown and Brent Taylor in 2009 and is headquartered in El Segundo, CA.

Beyond Meat Inc

Beyond Meat is trending as a high-volume meme stock, with traders actively debating its potential for a short squeeze despite concerns over the company's long-term profitability and underlying product demand. Community members are closely watching for volatility and price action, using the symbol as a centerpiece for discussions on short interest, technical gap fills, and broader market sentiment regarding retail-driven trading.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is experiencing an intense, high-conviction short squeeze driven by a extreme supply-demand imbalance, as two major investors reportedly hold an economic interest exceeding the entire float. The community is deeply divided between bulls anticipating a move to four-digit levels and bears warning of an inevitable, catastrophic collapse, while active traders closely monitor volatility halts and the high options premiums fueling the rapid price swings.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing a wave of positive sentiment as investors cheer strong quarterly earnings, upwardly revised profit guidance, and a newly announced share buyback program. The community is actively discussing the stock's renewed momentum, debating the potential for a short squeeze, and highlighting the company's defensive value proposition as a catalyst for a long-term turnaround.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors focus on a potential breakout from its consolidation pattern, fueled by optimism surrounding the company's vertically integrated housing transaction stack and upcoming earnings. The community is actively discussing a mix of technical indicators, high short interest, and the perceived long-term value of the company's AI-driven mortgage and title products.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community debates its long-term potential in AI data center power infrastructure, despite ongoing skepticism regarding its valuation relative to current revenue. Traders are actively monitoring potential short squeeze indicators, recent institutional activity, and the company's progress in securing design wins for its gallium nitride (GaN) technology.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing significant retail interest and a bullish sentiment surge following the announcement of a 100 million dollar share repurchase program. Investors are actively discussing the stock's potential for a short squeeze and long-term recovery, while highlighting recent structural catalysts like the termination of dilutive equity facilities and upcoming regulatory shifts favoring active trading.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a sharp surge in price and heavy institutional-grade volume, fueled by growing community speculation regarding deep-tech integration with major semiconductor players. Investors are actively dismissing recent short-seller reports as failed manipulation tactics, while focusing on the company's critical role in AI infrastructure and its upcoming efforts to streamline corporate operations.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is seeing intense volatility and massive retail-driven momentum as investors rally to force a short squeeze against heavy institutional positioning. Community sentiment is overwhelmingly bullish, fueled by the expansion into the high-demand peptide market and the belief that the stock's recent price recovery is just the beginning of a larger institutional re-rating.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing high momentum driven by significant insider confidence, as top executives recently converted corporate debt into equity at a premium to the current share price. The community is buzzing over these signals of long-term belief in the company's manufacturing technology for aerospace and defense, while keeping a close eye on potential contract wins and the upcoming earnings report.

Fitness Champs Holdings Ltd. engages in the provision of swimming lesson programs. It offers children weekly swimming program, ladies swimming, mixed adults swimming, private swimming, toddlers weekly swimming program and bukit canberra swimming complex, clementi swimming, delta swimming and sengkang swimming complex. The company was founded on February 15, 2024 and is headquartered in Singapore.

Fitness Champs Holdings Ltd. - Ordinary Shares - Class A

Fitness Champs Holdings Ltd.

Fitness Champs Holdings Ltd. is seeing intense volatility and high social media interest due to an exceptionally low public float, extremely high borrow fees, and massive short interest. Traders are hyper-focused on the aftermath of a public offering, with bullish sentiment driven by potential short squeeze setups and bearish concerns centered on potential dilution and reverse split risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ritholtz Wealth Management Acquires 72,999 Shares of Rigel Pharmaceuticals, Inc. $RIGL

Ritholtz Wealth Management increased its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 961.3% in the fourth quarter, according to its most recent Form 13F filing with the...

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire...

Hennion & Walsh Asset Management Inc. Makes New Investment in Rigel Pharmaceuticals, Inc. $RIGL

Hennion & Walsh Asset Management Inc. bought a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 52,189 shares of the biotechnology company...

Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology

Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology Rigel Announces Publication of Final ARROW...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendat...

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Madrigal (MDGL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Lowered to "Hold" at Wall Street Zen

Wall Street Zen cut Rigel Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Saturday...

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Down - What's Next?

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Down - Time to Sell...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have been assigned a consensus rating of "Hold" from the seven research firms that are covering the company, Marketbeat Ratings...

Rigel Pharmaceuticals Q4 Earnings Call Highlights

Rigel Pharmaceuticals (NASDAQ:RIGL) detailed record commercial performance for the fourth quarter and full year 2025, while outlining plans to pursue additional in-licensing opportunities and advance...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

RIGL
Rigel Pharmaceuticals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RIGL News

RIGLRigel Pharmaceuticals